Mammalian Target of Rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves

Namiko Abe, Steven H. Borson, Michael J. Gambello, Fan Wang, Valeria Cavalli

Research output: Contribution to journalArticle

129 Scopus citations

Abstract

Unlike neurons in the central nervous system (CNS), injured neurons in the peripheral nervous system (PNS) can regenerate their axons and reinnervate their targets. However, functional recovery in the PNS often remains suboptimal, especially in cases of severe damage. The lack of regenerative ability of CNS neurons has been linked to down-regulation of the mTOR (mammalian target of rapamycin) pathway. We report here that PNS dorsal root ganglial neurons (DRGs) activate mTOR following damage and that this activity enhances axonal growth capacity. Furthermore, genetic up-regulation of mTOR activity by deletion of tuberous sclerosis complex 2 (TSC2) in DRGs is sufficient to enhance axonal growth capacity in vitro and in vivo. We further show that mTOR activity is linked to the expression of GAP-43, a crucial component of axonal outgrowth. However, although TSC2 deletion in DRGs facilitates axonal regrowth, it leads to defects in target innervation. Thus, whereas manipulation of mTOR activity could provide new strategies to stimulate nerve regeneration in the PNS, fine control of mTOR activity is required for proper target innervation.

Original languageEnglish
Pages (from-to)28034-28043
Number of pages10
JournalJournal of Biological Chemistry
Volume285
Issue number36
DOIs
StatePublished - Sep 3 2010

Fingerprint Dive into the research topics of 'Mammalian Target of Rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves'. Together they form a unique fingerprint.

  • Cite this